Palatin Technologies - 22 Year Stock Price History | PTN

Historical daily share price chart and data for Palatin Technologies since 1997 adjusted for splits. The latest closing stock price for Palatin Technologies as of July 19, 2019 is 1.00.
  • The all-time high Palatin Technologies stock price is 96.30, which is 9530% above the current share price.
  • The Palatin Technologies 52-week high stock price is 1.64, which is 64% above the current share price.
  • The Palatin Technologies 52-week low stock price is 0.63, which is 37% below the current share price.
  • The average Palatin Technologies stock price for the last 52 weeks is 0.98.
Palatin Technologies Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 1.0457 0.7706 1.6400 0.6735 0.9983 40.92%
2018 0.9873 0.8400 1.4500 0.6308 0.7084 -17.52%
2017 0.5216 0.5490 1.0000 0.3000 0.8589 70.05%
2016 0.5363 0.6800 0.8200 0.3911 0.5051 -23.93%
2015 0.8710 0.8000 1.2700 0.6200 0.6640 -9.04%
2014 0.9697 0.7400 1.4400 0.6100 0.7300 -0.54%
2013 0.6416 0.6170 0.7820 0.5510 0.7340 22.35%
2012 0.6228 0.4203 0.7900 0.4203 0.5999 49.27%
2011 0.8409 1.4000 1.4000 0.4019 0.4019 -70.23%
2010 2.1510 3.4740 3.5000 0.8900 1.3500 -63.46%
2009 2.3024 1.0000 4.0000 0.7000 3.6950 311.01%
2008 1.9483 2.1000 4.2000 0.6060 0.8990 -55.05%
2007 14.1347 20.0000 23.3000 1.9000 2.0000 -90.20%
2006 25.1450 31.9000 37.2000 17.4000 20.4000 -37.42%
2005 22.8675 25.6000 40.3000 17.0000 32.6000 22.56%
2004 33.2456 26.7000 43.0000 23.5000 26.6000 6.40%
2003 28.9002 19.0000 58.6000 12.9000 25.0000 26.26%
2002 24.0992 40.0000 40.9000 11.0000 19.8000 -52.86%
2001 38.8785 36.2500 64.8000 20.5000 42.0000 24.44%
2000 53.3256 27.5000 92.5000 26.3000 33.7500 35.00%
1999 43.1983 38.1000 67.8000 23.7500 25.0000 -39.47%
1998 50.4484 60.0000 86.9000 16.9000 41.3000 -29.76%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.214B $0.067B
Palatin Technologies, Inc is a development-stage medical technology companyinvolved in developing and commercializing products and technologies fordiagnostic imaging, cancer therapy and ethical drug development These developments are based on its proprietary monoclonal antibody radiolabeling and enabling peptide platform technologies.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $109.508B 12.38
Gilead Sciences (GILD) United States $85.686B 10.40
Celgene (CELG) United States $64.115B 10.86
Vertex Pharmaceuticals (VRTX) United States $45.613B 55.14
Biogen (BIIB) United States $45.028B 8.55
Illumina (ILMN) United States $43.887B 50.86
CSL (CSLLY) Australia $36.043B 0.00
Regeneron Pharmaceuticals (REGN) United States $33.120B 15.57
Actelion (ALIOF) Switzerland $29.891B 0.00
Alexion Pharmaceuticals (ALXN) United States $27.639B 15.64
Incyte (INCY) United States $17.436B 70.70
Exact Sciences (EXAS) United States $15.096B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.897B 0.00
SINO PHARMACEUT (SBMFF) China $14.154B 0.00
Seattle Genetics (SGEN) United States $12.394B 0.00
Sarepta Therapeutics (SRPT) United States $11.244B 0.00
Genmab (GNMSF) Denmark $11.046B 56.15
Array BioPharma (ARRY) United States $10.373B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.283B 49.21
QIAGEN (QGEN) Netherlands $8.989B 29.53
Galapagos (GLPG) Belgium $8.915B 0.00
Guardant Health (GH) United States $8.160B 0.00
Bio-Techne Corp (TECH) United States $8.121B 55.41
Alnylam Pharmaceuticals (ALNY) United States $8.085B 0.00
Bluebird Bio (BLUE) United States $7.786B 0.00
Exelixis (EXEL) United States $6.678B 17.02
Amarin (AMRN) Ireland $6.250B 0.00
BeiGene (BGNE) Cayman Islands $5.802B 0.00
Ascendis Pharma (ASND) Denmark $4.892B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.842B 0.00
Blueprint Medicines (BPMC) United States $4.799B 0.00
Moderna (MRNA) United States $4.692B 0.00
Horizon Pharma Public (HZNP) Ireland $4.554B 11.73
Repligen (RGEN) United States $4.146B 103.28
Mirati Therapeutics (MRTX) United States $3.817B 0.00
Alkermes (ALKS) Ireland $3.810B 0.00
Spark Therapeutics (ONCE) United States $3.771B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.770B 0.00
China Biologic Products (CBPO) China $3.686B 23.41
Ultragenyx Pharmaceutical (RARE) United States $3.590B 0.00
MorphoSys AG (MOR) Germany $3.514B 0.00
Arena Pharmaceuticals (ARNA) United States $3.071B 6.24
Amicus Therapeutics (FOLD) United States $3.053B 0.00
Immunomedics (IMMU) United States $2.931B 0.00
UniQure (QURE) Netherlands $2.819B 0.00
Medicines (MDCO) United States $2.740B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.631B 0.00
Reata Pharmaceuticals (RETA) United States $2.613B 0.00
MyoKardia (MYOK) United States $2.467B 0.00
Halozyme Therapeutics (HALO) United States $2.443B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $2.260B 0.00
Acceleron Pharma (XLRN) United States $2.260B 0.00
Ligand Pharmaceuticals (LGND) United States $2.259B 18.71
Emergent Biosolutions (EBS) United States $2.258B 19.61
NeoGenomics (NEO) United States $2.245B 147.00
Intercept Pharmaceuticals (ICPT) United States $2.135B 0.00
Zai Lab (ZLAB) China $2.087B 0.00
Genomic Health (GHDX) United States $2.083B 44.24
Akcea Therapeutics (AKCA) United States $2.047B 0.00
Denali Therapeutics (DNLI) United States $1.986B 0.00
Myriad Genetics (MYGN) United States $1.958B 19.47
REGENXBIO (RGNX) United States $1.826B 0.00
Insmed (INSM) United States $1.699B 0.00
Cambrex (CBM) United States $1.534B 19.40
Fate Therapeutics (FATE) United States $1.467B 0.00
RA PHARMCTL INC (RARX) United States $1.457B 0.00
AnaptysBio (ANAB) United States $1.432B 0.00
Sangamo Therapeutics (SGMO) United States $1.402B 0.00
Innoviva (INVA) United States $1.368B 3.78
Athenex (ATNX) United States $1.307B 0.00
Alector (ALEC) United States $1.291B 0.00
Coherus BioSciences (CHRS) United States $1.254B 0.00
Editas Medicine (EDIT) United States $1.214B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.189B 0.00
Epizyme (EPZM) United States $1.161B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.078B 0.00
Codexis (CDXS) United States $1.028B 0.00
Cara Therapeutics (CARA) United States $1.007B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.001B 0.00
ANI Pharmaceuticals (ANIP) United States $0.976B 17.31
Twist Bioscience (TWST) United States $0.976B 0.00
Zymeworks (ZYME) Canada $0.960B 0.00
Principia Biopharma (PRNB) United States $0.957B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.911B 0.00
Retrophin (RTRX) United States $0.886B 0.00
Adverum Biotechnologies (ADVM) United States $0.878B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.856B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.844B 0.00
Vericel (VCEL) United States $0.841B 0.00
WAVE Life Sciences (WVE) Singapore $0.825B 0.00
Arvinas (ARVN) United States $0.791B 0.00
Intellia Therapeutics (NTLA) United States $0.787B 0.00
Precision BioSciences (DTIL) United States $0.746B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.705B 33.28
Zealand Pharma (ZEAL) Denmark $0.691B 8.07
Zealand Pharma (ZLDPF) Denmark $0.683B 0.00
Intra-Cellular Therapies (ITCI) United States $0.649B 0.00
Cytokineticsorporated (CYTK) United States $0.648B 0.00
Cellectis S.A (CLLS) France $0.634B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.631B 0.00
Heska (HSKA) United States $0.626B 64.12
Clovis Oncology (CLVS) United States $0.613B 0.00
DBV Technologies S.A (DBVT) France $0.606B 0.00
Stemline Therapeutics (STML) United States $0.604B 0.00
Anika Therapeutics (ANIK) United States $0.584B 19.94
Lexicon Pharmaceuticals (LXRX) United States $0.566B 0.00
Revance Therapeutics (RVNC) United States $0.566B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.560B 0.00
CytomX Therapeutics (CTMX) United States $0.555B 0.00
Pharming Group (PHGUF) Netherlands $0.521B 0.00
MiMedx (MDXG) United States $0.516B 0.00
Mesoblast (MESO) Australia $0.493B 0.00
UROGEN PHARMA (URGN) United States $0.447B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.442B 0.00
PHARMA MAR SA (PHMMF) Spain $0.441B 0.00
Puma Biotechnology (PBYI) United States $0.407B 0.00
Prothena (PRTA) Ireland $0.399B 0.00
PDL BioPharma (PDLI) United States $0.384B 9.17
Arcus Biosciences (RCUS) United States $0.380B 0.00
Biofrontera AG (BFRA) Germany $0.373B 0.00
Sinovac Biotech (SVA) China $0.371B 0.00
AC Immune SA (ACIU) Switzerland $0.370B 23.83
Gritstone Oncology (GRTS) United States $0.368B 0.00
Bellus Health (BLUSF) Canada $0.362B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.360B 0.00
Scholar Rock Holding (SRRK) United States $0.359B 0.00
Starpharma Holdings (SPHRY) Australia $0.355B 0.00
Avid Bioservices (CDMO) United States $0.351B 0.00
Albireo Pharma (ALBO) United States $0.350B 0.00
Merus (MRUS) Netherlands $0.341B 0.00
Agenus (AGEN) United States $0.340B 0.00
Kadmon Holdings (KDMN) United States $0.338B 0.00
BioDelivery Sciences (BDSI) United States $0.337B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.336B 0.00
Prometic Life Sciences (PFSCD) Canada $0.335B 0.00
Acorda Therapeutics (ACOR) United States $0.332B 5.84
Senesco Technologies (ELOX) United States $0.331B 0.00
Theratechnologies (THERF) Canada $0.331B 0.00
Syros Pharmaceuticals (SYRS) United States $0.321B 0.00
Sorrento Therapeutics (SRNE) United States $0.316B 0.00
Protagonist Therapeutics (PTGX) United States $0.311B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.304B 0.00
Cellular Biomedicine (CBMG) United States $0.287B 0.00
Inovio Pharmaceuticals (INO) United States $0.282B 0.00
Kindred Biosciences (KIN) United States $0.262B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.258B 0.00
Sutro Biopharma (STRO) United States $0.256B 0.00
PHASEBIO PHARMA (PHAS) United States $0.254B 0.00
ChromaDex (CDXC) United States $0.248B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.245B 0.00
Kamada (KMDA) Israel $0.240B 9.33
Dynavax Technologies (DVAX) United States $0.238B 0.00
Geron (GERN) United States $0.233B 0.00
ADMA Biologics Inc (ADMA) United States $0.224B 0.00
Athersys (ATHX) United States $0.223B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.222B 0.00
CorMedix Inc (CRMD) United States $0.215B 0.00
Cel-Sci (CVM) United States $0.212B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.202B 0.00
Five Prime Therapeutics (FPRX) United States $0.202B 0.00
MannKind (MNKD) United States $0.201B 0.00
Cerecor (CERC) United States $0.198B 0.00
Affimed (AFMD) Germany $0.197B 0.00
Abeona Therapeutics (ABEO) United States $0.189B 0.00
Pfenex (PFNX) United States $0.188B 0.00
OSMOTICA PHARM (OSMT) United States $0.187B 0.00
Mersana Therapeutics (MRSN) United States $0.186B 0.00
POXEL SA FRANCE (PXXLF) $0.184B 0.00
Synlogic (SYBX) United States $0.183B 0.00
Arsanis (XFOR) United States $0.182B 0.00
Spero Therapeutics (SPRO) United States $0.179B 0.00
Enzo Biochem (ENZ) United States $0.178B 0.00
Compugen (CGEN) Israel $0.174B 0.00
BioTime (BTX) United States $0.171B 11.40
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
Nicox SA (NICXF) France $0.162B 0.00
XOMA (XOMA) United States $0.161B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.156B 0.00
Cue Biopharma (CUE) United States $0.154B 0.00
Strongbridge Biopharma (SBBP) United States $0.153B 8.81
Liquidia Technologies (LQDA) United States $0.144B 0.00
OvaScience (MLND) United States $0.143B 0.00
Adocia (ADOCY) France $0.140B 0.00
TOCAGEN INC (TOCA) United States $0.140B 0.00
Celyad SA (CYAD) Belgium $0.139B 0.00
Dyadic (DYAI) United States $0.136B 0.00
Northwest Biotherapeutics (NWBO) United States $0.129B 0.00
Seres Therapeutics (MCRB) United States $0.129B 0.00
Aptinyx (APTX) United States $0.127B 0.00
Alcobra (ARCT) United States $0.125B 0.00
NantKwest (NK) United States $0.124B 0.00
Aduro Biotech (ADRO) United States $0.118B 0.00
Verastem (VSTM) United States $0.117B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.116B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.112B 0.00
Arbutus Biopharma (ABUS) Canada $0.111B 0.00
Novavax (NVAX) United States $0.109B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.105B 0.00
Menlo Therapeutics (MNLO) United States $0.104B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.103B 0.00
Checkpoint Therapeutics (CKPT) United States $0.102B 0.00
Catalyst Biosciences (CBIO) United States $0.101B 0.00
SESEN BIO, INC (SESN) United States $0.098B 0.00
Trevena (TRVN) United States $0.094B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.091B 0.00
Pluristem Therapeutics (PSTI) Israel $0.087B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.084B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.083B 0.00
Fortress Biotech (FBIO) United States $0.082B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.080B 0.00
Unum Therapeutics (UMRX) United States $0.080B 0.00
Selecta Biosciences (SELB) United States $0.077B 0.00
AquaBounty Technologies (AQB) United States $0.076B 0.00
Curis (CRIS) United States $0.075B 0.00
VBI Vaccines (VBIV) United States $0.075B 0.00
Orgenesis (ORGS) United States $0.073B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.073B 0.00
Idera Pharmaceuticals (IDRA) United States $0.073B 0.00
Signal Genetics (MGEN) United States $0.072B 0.00
VTv Therapeutics (VTVT) United States $0.071B 0.00
Applied Genetic Technologies (AGTC) United States $0.071B 38.80
Oncobiologics (OTLK) United States $0.069B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.066B 0.00
Organovo Holdings (ONVO) United States $0.063B 0.00
Alimera Sciences (ALIM) United States $0.061B 0.00
Antibe Therapeutics (ATBPF) Canada $0.060B 0.00
ARAVIVE, INC (ARAV) United States $0.060B 0.00
Prima BioMed (IMMP) Australia $0.059B 0.00
NewLink Genetics (NLNK) United States $0.058B 0.00
Protalix BioTherapeutics (PLX) Israel $0.057B 0.00
Invo BioScience (IVOB) United States $0.053B 0.00